Financhill
Sell
50

MIRM Quote, Financials, Valuation and Earnings

Last price:
$41.52
Seasonality move :
2.34%
Day range:
$41.17 - $42.40
52-week range:
$23.14 - $48.89
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
6.38x
P/B ratio:
8.60x
Volume:
215.7K
Avg. volume:
414.2K
1-year change:
38.26%
Market cap:
$2B
Revenue:
$186.4M
EPS (TTM):
-$2.07

Earnings Data

Next earnings date for MIRM
Feb 28
2025
Most recent earnings per share
-$0.30
Beat by $0.15
(Nov 12/2024)
Consensus Estimate
-$0.45
(Nov 12/2024)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

MIRM Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
02/28/2025 Q4 $95.4M -- -- -$0.29 --
11/12/2024 Q3 $82M $90.4M -$0.30 -$0.45 $0.15
08/07/2024 Q2 $75.1M $77.9M -$0.52 -$0.46 -$0.06
05/08/2024 Q1 $70.2M $69.2M -$0.54 -$0.30 -$0.24
02/28/2024 Q4 $67.9M $69.6M -$0.71 -$0.22 -$0.48
11/02/2023 Q3 -- -- -$0.57 -$0.81 $0.24
08/03/2023 Q2 -- -- -$1.94 -$0.79 -$1.15
05/04/2023 Q1 -- -- -$0.80 -$0.97 $0.17
03/08/2023 Q4 -- -- -$0.99 -$0.92 -$0.06
11/09/2022 Q3 -- -- -$1.02 -$1.09 $0.07
08/04/2022 Q2 -- -- -$0.84 -$1.06 $0.22
05/05/2022 Q1 -- -- -$1.17 -$1.38 $0.21
03/09/2022 Q4 -- -- $1.88 $1.84 $0.04
11/15/2021 Q3 -- -- -$1.55 -$1.50 -$0.05
08/05/2021 Q2 -- -- -$1.45 -$1.08 -$0.37
05/06/2021 Q1 -- -- -$1.68 -$0.99 -$0.70
03/09/2021 Q4 -- -- -$1.43 -$0.98 -$0.45
11/12/2020 Q3 -- -- -$0.86 -$0.98 $0.12
08/06/2020 Q2 -- -- -$0.93 -$0.87 -$0.06
05/07/2020 Q1 -- -- -$0.86 -$0.84 -$0.02
03/12/2020 Q4 -- -- -$0.79 -$0.85 $0.06
11/06/2019 Q3 -- -- -$0.84 -$0.63 -$0.21
08/28/2019 Q2 -- -- -$0.59 -$0.59 $0.00

Mirum Pharmaceuticals Earnings Questions

  • How Much did Mirum Pharmaceuticals Generate in Revenue Last Quarter?

    Mirum Pharmaceuticals reported $90.4M worth of top line sales in its most recent quarter.

  • Did Mirum Pharmaceuticals Beat Earnings Last Quarter?

    Mirum Pharmaceuticals announced earnings per share of -$0.30 which represents a beat of analyst forecast a -$0.45 per share.

  • Is Mirum Pharmaceuticals Profitable?

    Mirum Pharmaceuticals reported $69.6M that represents $1.46 per share over the last quarter.

  • What is the Analyst Consensus for Mirum Pharmaceuticals EPS Next Year?

    Mirum Pharmaceuticals's earnings are forecast to decrease from -$4.00 per share to -$3.50 per share next year representing a decrease of -63.52%.

  • When is Mirum Pharmaceuticals's Earnings Date?

    Mirum Pharmaceuticals's next earnings date is February 28, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Is Coinbase Stock Going Down?
Why Is Coinbase Stock Going Down?

Every way you look at it, Coinbase has had a…

Is Uber Stock a Buy on the Dip?
Is Uber Stock a Buy on the Dip?

Shares of Uber Technologies (NYSE:UBER) have been fading fast in…

Is AMD Stock an All-Time Buy?
Is AMD Stock an All-Time Buy?

Advanced Micro Devices (NASDAQ:AMD) is a high-growth AI stock that…

Stock Ideas

Buy
64
Is AAPL Stock a Buy?

Market Cap: $3.9T
P/E Ratio: 42x

Buy
52
Is NVDA Stock a Buy?

Market Cap: $3.4T
P/E Ratio: 115x

Buy
54
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 36x

Alerts

Sell
50
LMND alert for Dec 28

Lemonade [LMND] is down 10.69% over the past day.

Sell
50
TSLL alert for Dec 28

Direxion Daily TSLA Bull 2X Shares [TSLL] is down 9.92% over the past day.

Buy
63
SMLR alert for Dec 28

Semler Scientific [SMLR] is down 9.65% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock